Cargando…

Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma

BACKGROUND: Endoscopic resection (ER) has come to be recognized as a standard treatment for early gastric cancer (EGC). While its adoption is expanding, ER remains restricted to cases of EGC without lymph node metastasis for the treatment of local resection. On the other hand, histopathological anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Rieko, Omori, Tai, Mayanagi, Shuhei, Irino, Tomoyuki, Wada, Norihito, Kawakubo, Hirofumi, Kameyama, Kaori, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375195/
https://www.ncbi.nlm.nih.gov/pubmed/30760272
http://dx.doi.org/10.1186/s12957-019-1571-2
_version_ 1783395331353870336
author Nakamura, Rieko
Omori, Tai
Mayanagi, Shuhei
Irino, Tomoyuki
Wada, Norihito
Kawakubo, Hirofumi
Kameyama, Kaori
Kitagawa, Yuko
author_facet Nakamura, Rieko
Omori, Tai
Mayanagi, Shuhei
Irino, Tomoyuki
Wada, Norihito
Kawakubo, Hirofumi
Kameyama, Kaori
Kitagawa, Yuko
author_sort Nakamura, Rieko
collection PubMed
description BACKGROUND: Endoscopic resection (ER) has come to be recognized as a standard treatment for early gastric cancer (EGC). While its adoption is expanding, ER remains restricted to cases of EGC without lymph node metastasis for the treatment of local resection. On the other hand, histopathological analyses of surgically resected specimens of EGC have revealed the presence of lymph node (LN) metastasis in some cases of mucosal gastric cancer (MGC) and undifferentiated MGC (UD-MGC) is considered to have higher risk of nodal metastases than differentiated MGC (D-MGC). To evaluate the risk factors for LN metastasis in MGC, we investigated the characteristics of UD-MGC associated with LN metastasis. METHODS: Among all UD-MGC patients who underwent surgery as initial treatment, between January 2000 and March 2016, we reviewed the clinicopathological data, including the preoperative endoscopic findings and histopathological findings in the resected specimens, of the 11 UD-MGC patients who were identified as having lymph node metastasis. Furthermore, in comparison with cases without lymph node metastasis, we examined the possibility of expansion of the indication for local treatment. RESULTS: In most of the cases of UD-MGC with LN metastasis, the lesions were relatively large (> 20 mm in diameter) and of the clearly depressed type with faded color and apparent border, and histopathology revealed a high percentage of cases with lymphatic invasion and a predominance of signet ring cell carcinomas. No cases with LN metastasis without depressed macroscopic type nor signet ring cell carcinoma component existed. A degree of invasion of lamina propria (LP) or muscularis mucosae (MM) had same relation to the risk of LN metastasis. CONCLUSIONS: In this study, none of the cases of undifferentiated-type mucosal cancer (UD-MGC) with LN metastasis satisfied the current adoption criteria for ER. We suggested significant risk factors for LN metastasis in UD-MGC cases as depressed tumor type, presence of a signet ring cell carcinoma component, presence of lymphatic tumor invasion, and a large tumor size. More detailed analyses of the endoscopic and histopathological findings may allow further risk classification for LN metastasis in cases of UD-MGC.
format Online
Article
Text
id pubmed-6375195
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63751952019-02-26 Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma Nakamura, Rieko Omori, Tai Mayanagi, Shuhei Irino, Tomoyuki Wada, Norihito Kawakubo, Hirofumi Kameyama, Kaori Kitagawa, Yuko World J Surg Oncol Research BACKGROUND: Endoscopic resection (ER) has come to be recognized as a standard treatment for early gastric cancer (EGC). While its adoption is expanding, ER remains restricted to cases of EGC without lymph node metastasis for the treatment of local resection. On the other hand, histopathological analyses of surgically resected specimens of EGC have revealed the presence of lymph node (LN) metastasis in some cases of mucosal gastric cancer (MGC) and undifferentiated MGC (UD-MGC) is considered to have higher risk of nodal metastases than differentiated MGC (D-MGC). To evaluate the risk factors for LN metastasis in MGC, we investigated the characteristics of UD-MGC associated with LN metastasis. METHODS: Among all UD-MGC patients who underwent surgery as initial treatment, between January 2000 and March 2016, we reviewed the clinicopathological data, including the preoperative endoscopic findings and histopathological findings in the resected specimens, of the 11 UD-MGC patients who were identified as having lymph node metastasis. Furthermore, in comparison with cases without lymph node metastasis, we examined the possibility of expansion of the indication for local treatment. RESULTS: In most of the cases of UD-MGC with LN metastasis, the lesions were relatively large (> 20 mm in diameter) and of the clearly depressed type with faded color and apparent border, and histopathology revealed a high percentage of cases with lymphatic invasion and a predominance of signet ring cell carcinomas. No cases with LN metastasis without depressed macroscopic type nor signet ring cell carcinoma component existed. A degree of invasion of lamina propria (LP) or muscularis mucosae (MM) had same relation to the risk of LN metastasis. CONCLUSIONS: In this study, none of the cases of undifferentiated-type mucosal cancer (UD-MGC) with LN metastasis satisfied the current adoption criteria for ER. We suggested significant risk factors for LN metastasis in UD-MGC cases as depressed tumor type, presence of a signet ring cell carcinoma component, presence of lymphatic tumor invasion, and a large tumor size. More detailed analyses of the endoscopic and histopathological findings may allow further risk classification for LN metastasis in cases of UD-MGC. BioMed Central 2019-02-13 /pmc/articles/PMC6375195/ /pubmed/30760272 http://dx.doi.org/10.1186/s12957-019-1571-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nakamura, Rieko
Omori, Tai
Mayanagi, Shuhei
Irino, Tomoyuki
Wada, Norihito
Kawakubo, Hirofumi
Kameyama, Kaori
Kitagawa, Yuko
Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title_full Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title_fullStr Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title_full_unstemmed Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title_short Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
title_sort risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375195/
https://www.ncbi.nlm.nih.gov/pubmed/30760272
http://dx.doi.org/10.1186/s12957-019-1571-2
work_keys_str_mv AT nakamurarieko riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT omoritai riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT mayanagishuhei riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT irinotomoyuki riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT wadanorihito riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT kawakubohirofumi riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT kameyamakaori riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma
AT kitagawayuko riskoflymphnodemetastasisinundifferentiatedtypemucosalgastriccarcinoma